Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.76 USD -0.26 USD ( -3.24% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Wall Street
Price Targets

ADCT Price Targets
Price Targets made by Wall Street

Wall Street analysts forecast ADCT stock price to rise over the next 12 months.

12-month price targets for ADCT stock made by Wall Street professionals. The average price target is 29.92 USD with a low forecast of 17.17 USD and a high forecast of 56.7 USD.

Lowest
Price Target
17.17 USD
121% Upside
Average
Price Target
29.92 USD
286% Upside
Highest
Price Target
56.7 USD
631% Upside
ADC Therapeutics SA Competitors:
Price Targets
SGMO
Sangamo Therapeutics Inc
260% Upside
RPTX
Repare Therapeutics Inc
159% Upside
IMV
IMV Inc
345% Upside
DSGN
Design Therapeutics Inc
82% Upside
FGEN
FibroGen Inc
15% Upside
AVCT
Avacta Group PLC
58% Upside
KRYS
Krystal Biotech Inc
56% Upside
JSPR
Jasper Therapeutics Inc
580% Upside

Revenue
Forecast

ADCT Revenue Forecast
Wall Street Forecast

ADC Therapeutics SA's Revenue forecast for three years ahead made by Wall Street analysts. Revenue is forecast to grow at a rate of 107% per year.

Year Avg Range
2024
By 7 analysts
300M USD
+83%
256M - 362M USD
2023
By 8 analysts
164M USD
+27%
121M - 205M USD
2022
By 9 analysts
129M USD
+281%
83.4M - 193M USD
CAGR:
Forecast
107%

Operating Income
Forecast

ADCT Operating Income Forecast
Wall Street Forecast

ADC Therapeutics SA's Operating Income forecast for three years ahead made by Wall Street analysts. Operating Income is forecast to grow at a rate of -7% per year.

Year Avg Range
2024
By 8 analysts
-220.4M USD
+19%
(-308M) - (-117.1M) USD
2023
By 8 analysts
-272.5M USD
-11%
(-303.8M) - (-201.7M) USD
2022
By 9 analysts
-245.9M USD
+9%
(-268.5M) - (-220.6M) USD
CAGR:
Forecast
-7%

Net Income
Forecast

ADCT Net Income Forecast
Wall Street Forecast

ADC Therapeutics SA's Net Income forecast for three years ahead made by Wall Street analysts. Net Income is forecast to grow at a rate of -8% per year.

Year Avg Range
2024
By 7 analysts
-179.6M USD
+24%
(-219.7M) - (-109.9M) USD
2023
By 8 analysts
-235.1M USD
-15%
(-268.9M) - (-187.9M) USD
2022
By 9 analysts
-205.1M USD
+11%
(-230.8M) - (-156M) USD
CAGR:
Forecast
-8%

See Also

Other Stocks